- Home
- ISPO vs EDSA Comparison
ISPO vs EDSA Comparison
Compare ISPO & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- EDSA
- Stock Information
- Founded
- ISPO 2010
- EDSA 2015
- Country
- ISPO United States
- EDSA Canada
- Employees
- ISPO N/A
- EDSA N/A
- Industry
- ISPO Blank Checks
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- EDSA Health Care
- Exchange
- ISPO Nasdaq
- EDSA Nasdaq
- Market Cap
- ISPO 13.4M
- EDSA 13.5M
- IPO Year
- ISPO N/A
- EDSA N/A
- Fundamental
- Price
- ISPO $3.93
- EDSA $4.10
- Analyst Decision
- ISPO Buy
- EDSA Strong Buy
- Analyst Count
- ISPO 2
- EDSA 1
- Target Price
- ISPO $10.50
- EDSA $21.00
- AVG Volume (30 Days)
- ISPO 24.7K
- EDSA 14.3K
- Earning Date
- ISPO 11-04-2024
- EDSA 12-13-2024
- Dividend Yield
- ISPO N/A
- EDSA N/A
- EPS Growth
- ISPO N/A
- EDSA N/A
- EPS
- ISPO N/A
- EDSA N/A
- Revenue
- ISPO $300,935,000.00
- EDSA N/A
- Revenue This Year
- ISPO N/A
- EDSA N/A
- Revenue Next Year
- ISPO N/A
- EDSA N/A
- P/E Ratio
- ISPO N/A
- EDSA N/A
- Revenue Growth
- ISPO N/A
- EDSA N/A
- 52 Week Low
- ISPO $3.11
- EDSA $2.50
- 52 Week High
- ISPO $9.31
- EDSA $6.46
- Technical
- Relative Strength Index (RSI)
- ISPO 46.23
- EDSA 42.79
- Support Level
- ISPO $3.91
- EDSA $4.20
- Resistance Level
- ISPO $4.37
- EDSA $4.36
- Average True Range (ATR)
- ISPO 0.22
- EDSA 0.28
- MACD
- ISPO 0.00
- EDSA -0.02
- Stochastic Oscillator
- ISPO 13.85
- EDSA 10.00
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.